NEMLUVIO® (nemolizumab-ilto) Is Now Available For Patients Dealing With Prurigo Nodularis

10/08/2024

AcariaHealth has teamed up with Galderma to bring you NEMLUVIO® (nemolizumab-ilto) and our enhanced specialty pharmacy services. This new treatment is the first of its kind designed to block IL-31 signaling, a key driver of itch, inflammation, and the formation of prurigo nodularis nodules.

What Is NEMLUVIO®?
NEMLUVIO® is an advanced medication that allows your skin to heal by relieving itch and reducing the urge to scratch. It works by blocking IL-31, a key protein in the body that sends signals to the brain that cause you to itch, triggering the persistent itch-scratch cycle. NEMLUVIO® can provide much-needed relief for those struggling with this tough condition.

Understanding Prurigo Nodularis
Prurigo nodularis is a skin condition that causes hard, raised bumps on the skin, often covered with thick, dry crusts. These bumps can be intensely itchy, especially at night, and commonly appear on the abdomen, arms, legs, and scalp. The constant itching can lead to bleeding and scarring, which makes finding an effective treatment crucial.

How AcariaHealth Can Support You
At AcariaHealth, we’re dedicated to making a real difference in your life. We don’t just deliver medication; we offer compassionate support and care throughout your treatment journey. Our goal is to ensure you get the medication you need along with the support to manage your condition effectively.

Want to Learn More?

If you’re interested in NEMLUVIO® or need more information, you can download our referral form. For detailed prescribing information, check out nemluvio.com, and for more resources, visit nemluviohcp.com.

Stay updated with AcariaHealth by following us on LinkedIn. We’re excited to keep you informed with the latest news and updates!